Soligenix News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Soligenix Inc SNGX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.16 7.37% 2.33 2.13 2.36 2.15 2.17 19:57:14
more quote information »

Recent News

Date Time Source Heading
7/31/202016:32EDGARSecurities Registration Statement (simplified Form) (s-3/a)
7/28/202007:00PRNUSSoligenix Announces Publication of Positive Pre-clinical..
7/24/202016:30EDGARProxy Statement - Notice of Shareholders Meeting..
7/20/202007:00EDGARCurrent Report Filing (8-k)
7/20/202007:00PRNUSSoligenix Issues Corporate Update - Highlights Important..
7/17/202016:48EDGARSecurities Registration Statement (simplified Form) (s-3)
6/24/202007:00PRNUSSoligenix Completes Enrollment in its Pivotal Phase 3..
6/22/202007:00PRNUSSoligenix to Join Russell Microcap® Index
6/19/202016:31EDGARStatement of Changes in Beneficial Ownership (4)
6/09/202007:00PRNUSSoligenix to Present at the MedInvest Infectious Disease and..
5/15/202016:10EDGARQuarterly Report (10-q)
5/15/202007:00PRNUSSoligenix Announces Recent Accomplishments And First Quarter..
5/11/202007:00PRNUSSoligenix Announces Publication of Correlates of Immune..
5/07/202007:00PRNUSSoligenix Receives $840,000 in Non-Dilutive Funding Through..
5/06/202016:02EDGARAmended Statement of Ownership (sc 13g/a)
4/30/202007:05EDGARCurrent Report Filing (8-k)
4/30/202007:00PRNUSSoligenix Announces Positive Phase 3 FLASH Study..
4/23/202016:06EDGARAmended Statement of Ownership (sc 13g/a)
4/16/202007:00PRNUSSoligenix Announces Exclusive Licensing Agreement for Novel..
4/13/202008:02EDGARCurrent Report Filing (8-k)
4/10/202016:18EDGARCurrent Report Filing (8-k)
4/10/202016:17EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
4/06/202007:00PRNUSSoligenix Receives European Patent for Therapeutic Use of..
4/03/202016:12EDGARCurrent Report Filing (8-k)
3/30/202016:05EDGARAnnual Report (10-k)
3/30/202007:00PRNUSSoligenix Announces Recent Accomplishments And Year-End 2019..
3/23/202007:00PRNUSSoligenix and University of Hawaiʻi at Mānoa Initiate Work..
3/20/202016:07EDGARCurrent Report Filing (8-k)
3/20/202016:07EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/19/202006:06EDGARCurrent Report Filing (8-k)
3/19/202006:00PRNUSSoligenix Announces Positive Top-line Results for its..
2/27/202007:00PRNUSSoligenix Announces Successful Demonstration of Heat..
2/13/202007:00PRNUSFDA Grants Soligenix "Fast Track" Designation for RiVax® in..
2/11/202007:00PRNUSSoligenix Announces SGX301 Patient Case Study Presentation..
2/07/202015:26EDGARAmended Statement of Ownership (sc 13g/a)
2/03/202007:00PRNUSSoligenix Announces Japanese Patent Allowance for Use of..
1/30/202007:00PRNUSSoligenix to Present at the 22nd Annual BIO CEO & Investor..
1/14/202007:00PRNUSSoligenix - Advancing to Important Inflection Points With..
1/03/202016:32EDGARCurrent Report Filing (8-k)
1/02/202016:31EDGARStatement of Changes in Beneficial Ownership (4)
12/18/201907:00PRNUSSoligenix to Receive $850,000 in Non-Dilutive Funding..
12/17/201912:15EDGARCurrent Report Filing (8-k)
12/13/201916:32EDGARStatement of Changes in Beneficial Ownership (4)
12/13/201916:31EDGARStatement of Changes in Beneficial Ownership (4)
12/13/201916:31EDGARStatement of Changes in Beneficial Ownership (4)
12/13/201916:31EDGARStatement of Changes in Beneficial Ownership (4)
12/12/201907:00PRNUSSoligenix Initiates Clinical Trial of its Heat Stable Ricin..
12/03/201907:00PRNUSSoligenix Completes Enrollment in its Pivotal Phase 3..
11/19/201916:20EDGARStatement of Changes in Beneficial Ownership (4)
11/19/201916:19EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.